352 related articles for article (PubMed ID: 17174516)
21. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
Lunde OC; Havig O
Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
24. Outcome after curative resection for locally recurrent rectal cancer.
Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
[TBL] [Abstract][Full Text] [Related]
25. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
[TBL] [Abstract][Full Text] [Related]
26. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T
Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458
[TBL] [Abstract][Full Text] [Related]
27. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
[TBL] [Abstract][Full Text] [Related]
28. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence.
Alexander-Sefre F; Chandrakumaran K; Banerjee S; Sexton R; Thomas JM; Moran B
Colorectal Dis; 2005 Jul; 7(4):382-6. PubMed ID: 15932563
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
Lumachi F; Brandes AA; Boccagni P; Polistina F; Favia G; D'Amico DF
Anticancer Res; 1999; 19(5C):4485-9. PubMed ID: 10650797
[TBL] [Abstract][Full Text] [Related]
30. Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.
Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Laurberg S; Brünner N; Nielsen HJ
Anticancer Res; 2010 Nov; 30(11):4755-9. PubMed ID: 21115936
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
33. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
[TBL] [Abstract][Full Text] [Related]
34. [CEA determination in the follow-up of colorectal cancers].
Lauterbach M; Dehne A; Hesse V; Höfig G
Zentralbl Chir; 1987; 112(15):968-74. PubMed ID: 3673304
[TBL] [Abstract][Full Text] [Related]
35. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
[TBL] [Abstract][Full Text] [Related]
36. Pattern of carcinoembryonic antigen drop after laparoscopic radiofrequency ablation of liver metastasis from colorectal carcinoma.
Ghanamah M; Berber E; Siperstein A
Cancer; 2006 Jul; 107(1):149-53. PubMed ID: 16736515
[TBL] [Abstract][Full Text] [Related]
37. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?
Mackay G; Downey M; Molloy RG; O'Dwyer PJ
Colorectal Dis; 2006 Jan; 8(1):34-6. PubMed ID: 16519635
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
39. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]